Index Rebal/Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Index Rebal/Special Situations

Quiddity Advisors

Pan-Asia Catalysts/Events

Index Rebalance

<ul>
<li>JPX-Nikkei 400 is composed of common stocks listed on the Tokyo Stock Exchange. The index has a complex selection methodology that considers size, fundamentals, and governance factors.</li>
<li>The annual index review takes place in August every year. We look at the latest rankings of potential ADDs/DELs each month.</li>
<li>Below is a look at potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance scheduled for August 2026 based on trading data as of end-March 2026.</li>
</ul>


JPX-Nikkei 400 is composed of common stocks listed on the Tokyo Stock Exchange. The index has a complex selection methodology that considers size, fundamentals, and governance factors.
The annual index review takes place in August every year. We look at the latest rankings of potential ADDs/DELs each month.
Below is a look at potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance scheduled for August 2026 based on trading data as of end-March 2026.


Quiddity JPX-Nikkei 400 Rebal 2026: End-Mar 2026 Ranks

HK/China Equity Long-Short

Osbert Tang, CFA

Equity Capital Markets

Epiworld International / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/epiworld-international-co-ltd" target="_blank" data-smartkarma-citation="entities:47626:1" rel="noopener">EpiWorld International (2726 HK)</a>, while it is a global leader in the silicon carbide (SiC) epitaxy industry, has a weak profit record. Its IPO price looks demanding. </li>
<li>Its net profit will likely be relatively flat in FY26, before picking up in FY27 and FY28. However, whether the industry will bottom in 2H26 remains an unknown.</li>
<li>The stock's valuations of 117x PER and 35.6x P/S are not cheap relative to peers, implying that risks outweigh returns in its H-share IPO.</li>
</ul>



EpiWorld International (2726 HK), while it is a global leader in the silicon carbide (SiC) epitaxy industry, has a weak profit record. Its IPO price looks demanding. 
Its net profit will likely be relatively flat in FY26, before picking up in FY27 and FY28. However, whether the industry will bottom in 2H26 remains an unknown.
The stock's valuations of 117x PER and 35.6x P/S are not cheap relative to peers, implying that risks outweigh returns in its H-share IPO.


EpiWorld Intl (2726 HK) IPO: A Pricy (And Risky) Choice

Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/paypay-corporation" target="_blank" data-smartkarma-citation="entities:35269:1" rel="noopener">PayPay (PAYP US)</a>, a payments and financial services platform, raised around US$880m in its US IPO after pricing below the range.</li>
<li>PP operates a digital finance platform that serves as a payment solution for users and merchants, along with offering additional services.</li>
<li>We have looked at its past performance and valuations in our earlier notes. In this note, we talk about the trading dynamics.</li>
</ul>



PayPay (PAYP US), a payments and financial services platform, raised around US$880m in its US IPO after pricing below the range.
PP operates a digital finance platform that serves as a payment solution for users and merchants, along with offering additional services.
We have looked at its past performance and valuations in our earlier notes. In this note, we talk about the trading dynamics.


Aequitas: PayPay IPO Trading - Valuations Digestible, Sentiment Suffering

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

<ul>
<li>Since the announcement of the US$1.5 billion secondary offering, <a href="https://www.smartkarma.com/entities/nintendo-co-ltd" target="_blank" data-smartkarma-citation="entities:5415:1" rel="noopener">Nintendo (7974 JP)</a>’s shares have declined 3.5% to the undisturbed price of JPY8,995 per share (26 February).</li>
<li>It is instructive to look at recent large Japanese placements to understand the potential trading pattern. Nintendo's share decline is lower than the median of recent large placements.</li>
<li>The offering will likely be priced on 9 March. The average large Japanese placement tends to generate positive returns.</li>
</ul>


Since the announcement of the US$1.5 billion secondary offering, Nintendo (7974 JP)’s shares have declined 3.5% to the undisturbed price of JPY8,995 per share (26 February).
It is instructive to look at recent large Japanese placements to understand the potential trading pattern. Nintendo's share decline is lower than the median of recent large placements.
The offering will likely be priced on 9 March. The average large Japanese placement tends to generate positive returns.


<ul>
<li>
<a href="https://www.smartkarma.com/entities/paypay-corporation" target="_blank" data-smartkarma-citation="entities:35269:1" rel="noopener">PayPay (PAYP US)</a> (PP), a payments and financial services platform, is now looking to raise up to US$1.1bn in its upcoming US IPO.</li>
<li>PP operates a digital finance platform that serves as a payment solution for users and merchants, along with offering additional services.</li>
<li>We have looked at its past performance and undertaken a peer comparison in our earlier notes. In this note, we provide our thoughts on valuations.</li>
</ul>



PayPay (PAYP US) (PP), a payments and financial services platform, is now looking to raise up to US$1.1bn in its upcoming US IPO.
PP operates a digital finance platform that serves as a payment solution for users and merchants, along with offering additional services.
We have looked at its past performance and undertaken a peer comparison in our earlier notes. In this note, we provide our thoughts on valuations.


Aequitas: PayPay IPO - Thoughts on Valuations

Japan

Resonac Holdings Corporation manufactures and distributes chemical products. The Company produces synthetic resins, petrochemical products, inorganics, and other related products. Resonac Holdings also produces ceramics, metals, carbon, electronic materials, and other products.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Resonac Holdings (4004 JP)

Quiddity JPX-Nikkei 400 Rebal 2026: End-Mar 2026 Ranks

There are currently 50 Potential ADDs and 48 Potential DELs (unique names) presented in the current Quiddity Leaderboard. There are three months...

Janaghan Jeyakumar, CFA

EpiWorld Intl (2726 HK) IPO: A Pricy (And Risky) Choice

EpiWorld International is a global leader in SiC epitaxy but has a weak profit record, with a demanding IPO price and an uncertain industry...

Osbert Tang, CFA

Aequitas: PayPay IPO Trading - Valuations Digestible, Sentiment Suffering

PayPay (PAYP US), a payments and financial services platform, raised around US$880m in its US IPO after pricing below the range. In this note, we...

Sumeet Singh

Nintendo (7974 JP): The Current Playbook

The offering, which was reduced due to the ToSTNeT-3 repurchase, will likely be priced on 9 March. The average large Japanese placement tends to...

Arun George

Aequitas: PayPay IPO - Thoughts on Valuations

PayPay (PAYP US) (PP), a payments and financial services platform, is now looking to raise up to US$1.1bn in its upcoming US IPO. In this note, we...

Sumeet Singh

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Quiddity JPX-Nikkei 400 Rebal 2026: End-Mar 2026 Ranks

There are currently 50 Potential ADDs and 48 Potential DELs (unique names) presented in the current Quiddity Leaderboard. There are three months...

Janaghan Jeyakumar, CFA

EpiWorld Intl (2726 HK) IPO: A Pricy (And Risky) Choice

​EpiWorld International is a global leader in SiC epitaxy but has a weak profit record, with a demanding IPO price and an uncertain industry...

Osbert Tang, CFA

Aequitas: PayPay IPO Trading - Valuations Digestible, Sentiment Suffering

PayPay (PAYP US), a payments and financial services platform, raised around US$880m in its US IPO after pricing below the range. In this note, we...

Sumeet Singh

Nintendo (7974 JP): The Current Playbook

The offering, which was reduced due to the ToSTNeT-3 repurchase, will likely be priced on 9 March. The average large Japanese placement tends to...

Arun George

Aequitas: PayPay IPO - Thoughts on Valuations

PayPay (PAYP US) (PP), a payments and financial services platform, is now looking to raise up to US$1.1bn in its upcoming US IPO. In this note, we...

Sumeet Singh

EpiWorld International is a global leader in SiC epitaxy but has a weak profit record, with a demanding IPO price and an uncertain industry...